Effects of selenium on peripheral blood mononuclear cell membrane fluidity, interleukin-2 production and interleukin-2 receptor expression in patients with chronic hepatitis

Table 3 IL-2 and IL-2R expression in PBMCs of patients before and after selenium treatment (mean ± SD)

Groups	Cases	IL-2 activation (1 × 103U/L)	IL-2R expression (%)
Before treatment
Normal control group	22	43.22 ± 9.25	31.24 ± 5.20
Selenium treated group	23	42.26 ± 9.55	31.05 ± 5.09
After treatment
Normal control group	18	49.45 ± 15.25	35.12 ± 6.49
Selenium treated group	17	60.32 ± 13.28a	46.05 ± 4.46b

^bP < 0.01 vs before treatment.